PFS results were supported by the secondary end point of overall survival , with an ITT HR of @ ( @ % CI , @ to @ ; P = @ ) ; in patients with centrally confirmed HER@-positive tumors , the HR was @ ( @ % CI , @ to @ ; P = @ ) .